Clinical trial
Effectiveness of the Diaphragm for HIV Prevention
NCT00121459 · University of California, San Francisco, Other · Withdrawn
Key facts
| NCT number | NCT00121459 |
|---|---|
| Title | Effectiveness of the Diaphragm for HIV Prevention |
| Official title | The Latex Diaphragm to Prevent HIV Acquisition Among Women: A Female-Controlled, Physical Barrier of the Cervix |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | Bill and Melinda Gates Foundation Ibis Reproductive Health Medical Research Council, South Africa Women's Health Global Imperative UZ-UCSF Collaborative Research Programme Perinatal HIV Research Unit… |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Device |
| Interventions | Ortho All-Flex diaphragm and Replens lubricant gel |
| Enrollment | 0 |
| Start date | Sep 1, 2003 |
| First posted | Jul 21, 2005 |
| Last update posted | Mar 4, 2015 |
| Countries | South Africa, Zimbabwe |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: